Need professional-grade analysis? Visit stockanalysis.com
$54.62M
N/A
N/A
N/A
OS Therapies Incorporated (OSTX) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.43, up 3.62% from the previous close.
Over the past year, OSTX has traded between a low of $1.16 and a high of $2.50. The stock has lost 11.2% over this period. It is currently 42.8% below its 52-week high.
OS Therapies Incorporated has a market capitalization of $54.62M.
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Grasonville, Maryland.
Side-by-side comparison against top Healthcare peers.